Skip to main content

Table 10 Change from Baseline in Low-Density Lipoprotein Cholesterol and Glucose

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO − 0.50 [− 4.09, 3.14] −0.67 [− 3.23, 0.42] 0.42 [− 1.23, 2.16] −0.59 [− 4.23, 3.00] 1.18 [− 3.86, 6.23]
0.90 [− 2.17, 4.12] ARI − 0.17 [− 4.61, 3.60] 0.92 [− 3.03, 4.83] −0.09 [− 5.29, 4.95] 1.67 [− 4.52, 7.81]
0.07 [− 1.31, 1.70] − 0.83 [− 4.29, 2.59] CAR 1.09 [− 0.48, 4.43] 0.08 [− 3.80, 4.44] 1.84 [− 3.28, 7.39]
−0.34 [− 3.18, 2.17] −1.25 [− 5.62, 2.71] −0.42 [− 3.78, 2.39] OLA −1.01 [− 5.01, 2.96] 0.75 [− 4.51, 6.04]
1.15 [− 0.82, 3.12] 0.25 [− 3.56, 3.91] 1.08 [− 1.46, 3.44] 1.50 [− 1.72, 4.94] QUE 1.76 [− 4.42, 7.84]
−1.45 [−5.50, 2.64] − 2.35 [− 7.61, 2.73] −1.52 [− 5.85, 2.77] −1.11 [− 5.85, 3.94] −2.60 [− 7.12, 1.92] LUR
  1. Note: Low-Density Lipoprotein results are on the top-right and Glucose results are on the bottom-left. Numbers represent the mean change [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine